AGEs induce MMP-9 promoter demethylation through the GADD45α-mediated BER pathway to promote breast cancer metastasis in patients with diabetes
Endocrine-Related Cancer · 2024
DOI: 10.1530/erc-23-0330 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrine-Related Cancer, 2024. Verfasst von Liyan Zhou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Phase I Clinical Trial, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin…. Hauptthemen laut MEDLINE: Breast Neoplasms, Matrix Metalloproteinase 9, Glycation End Products, Advanced, Cell Cycle Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Scientific evidence has linked diabetes to a higher incidence and increased aggressiveness of breast cancer; however, mechanistic studies of the numerous regulators involved in this process are insufficiently thorough. Advanced glycation end products (AGEs) play an important role in the chronic complications of diabetes, but the mechanisms of AGEs in breast cancer are largely unexplored. In this study, we first demonstrate that high AGE levels in breast cancer tissues are associated with the diabetic state and poor patient outcomes. Furthermore, AGEs interact with the receptor for AGEs (RAGE) to promote breast cancer cell migration and invasion. Mechanistically, based on RNA sequencing (RNA-seq) analysis, we reveal that growth arrest and DNA damage gene 45α (GADD45α) is a vital protein upregulated by AGEs through a P53-dependent pathway. Next, GADD45α recruits thymine DNA glycosylase for base excision repair to form the demethylation complex at the promoter region of MMP-9 and enhance MMP-9 transactivation through DNA demethylation. Overall, our results indicate a critical regulatory role of AGEs in patients with breast cancer and diabetes and reveal a novel mechanism of epigenetic modification in promoting breast cancer metastasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Phase I Clinical Trial, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Breast Cance…
- Department of Breast Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Preve…
ORCID-Profile: Liyan Zhou
Zitieren
APA
Zhou, L., Bai, G., Song, Y., Liu, X., Li, X., Deng, Y., Si, Y., Shi, Y., & Li, H. (2024). AGEs induce MMP-9 promoter demethylation through the GADD45α-mediated BER pathway to promote breast cancer metastasis in patients with diabetes. Endocrine-Related Cancer. https://doi.org/10.1530/erc-23-0330
Vancouver
Zhou L, Bai G, Song Y, Liu X, Li X, Deng Y, et al. AGEs induce MMP-9 promoter demethylation through the GADD45α-mediated BER pathway to promote breast cancer metastasis in patients with diabetes. Endocrine-Related Cancer. 2024. doi:10.1530/erc-23-0330
BibTeX
@article{Zhou2024,
author = {Zhou, Liyan and Bai, Guiying and Song, Yue and Liu, Xiaohui and Li, Xiaoqing and Deng, Yilin and Si, Yiran and Shi, Yehui and Li, Hongli},
title = {AGEs induce MMP-9 promoter demethylation through the GADD45α-mediated BER pathway to promote breast cancer metastasis in patients with diabetes},
journal = {Endocrine-Related Cancer},
year = {2024},
doi = {10.1530/erc-23-0330}
}
EUVIMED